We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Droplet Digital PCR Detects Schistosomiasis DNA in Samples

By LabMedica International staff writers
Posted on 08 Nov 2017
Schistosoma japonicum is the only human blood fluke that occurs in China and Philippines and also in Sri Lanka. More...
It is the cause of schistosomiasis japonica, a disease that still remains a significant health problem especially in lake and marshland regions.

Microscopic identification of eggs in stool or urine is the most practical method for diagnosis. Stool examination should be performed when infection with S. mansoni or S. japonicum is suspected, and urine examination should be performed if S. haematobium is suspected.

An international team of scientists led by those at the QIMR Berghofer Medical Research Institute (Brisbane, Australia) have used a previously reported a novel droplet digital-polymerase chain reaction (ddPCR) assay targeting the mitochondrial NADH dehydrogenase subunit I gene (nad1) to diagnose schistosomiasis japonica. The tool identified both pre-patent and patent infections using S. japonicum DNA isolated from serum, urine, salivary glands and feces in a murine model. The assay was validated here using clinical samples collected from 412 subjects resident in an area moderately endemic for schistosomiasis in the Philippines.

The team reported that S. japonicum DNA present in human stool, serum, urine and saliva was detected quantitatively with high sensitivity. The capability to diagnose cases of human schistosomiasis using non-invasively collected clinical samples, the higher level of sensitivity obtained compared with the microscopy-based Kato-Katz test, and the capacity to quantify infection intensity, have important public health implications for schistosomiasis control and programs targeting other neglected tropical diseases.

The authors concluded that the verified ddPCR method represents a valuable new tool for the diagnosis and surveillance of schistosomiasis, particularly in low prevalence and low intensity areas approaching elimination and in monitoring areas where disease emergence or re-emergence is a concern. The study was published on September 27, 2017, in the Journal of Infectious Diseases.

Related Links:
QIMR Berghofer Medical Research Institute


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.